Literature DB >> 15550571

Raloxifene relaxes rat pulmonary arteries and veins: roles of gender, endothelium, and antagonism of Ca2+ influx.

Yau-Chi Chan1, Fung-Ping Leung, Xiaoqiang Yao, Chi-Wai Lau, Paul M Vanhoutte, Yu Huang.   

Abstract

Effects of raloxifene have been documented in the systemic circulation. However, its impact on the pulmonary circulation is unclear. The present study investigated the role of gender, endothelial modulation, and Ca(2+) channel in relaxations evoked by raloxifene in rat pulmonary arteries and veins. Vascular responses were studied on isolated pulmonary blood vessels mounted in a myograph and constricted by U46619 (9,11-dideoxy-11alpha,9alpha-epoxymethanoprostaglandin F(2alpha)). Constrictions to CaCl(2) were studied in Ca(2+)-free, 60 mM K(+) solution. Changes in the intracellular calcium ion concentration ([Ca(2+)](i)) in vascular smooth muscle were measured using a calcium fluorescence imaging method. Raloxifene was more effective in relaxing U46619-constricted pulmonary arteries from male than female rats. Raloxifene-induced relaxation was unaffected by ICI 182,780 [7alpha-[9-[(4,4,5,5,5,-pentafluoropentyl)-sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17beta-diol], inhibition of the nitric oxide (NO) pathway, or removal of the endothelium. In arteries without endothelium, raloxifene attenuated CaCl(2)-induced constriction and CaCl(2)-stimulated increase in [Ca(2+)](i) with similar potencies. Raloxifene caused endothelium-independent relaxations in pulmonary veins, albeit to a lesser degree than in pulmonary arteries. The venous responses showed a gender difference because raloxifene was more potent in male veins. In summary, raloxifene relaxed rat pulmonary arteries, and this effect did not involve the endothelium/NO or ICI 182,780-sensitive estrogen receptors. Raloxifene, like nifedipine, reduced constriction and [Ca(2+)](i) increase in response to CaCl(2) in high K(+) solution. Raloxifene also relaxed high K(+)-constricted pulmonary veins. Our data indicate that raloxifene acutely relaxes rat pulmonary blood vessels primarily via inhibition of Ca(2+) influx through voltage-sensitive Ca(2+) channels. Finally, raloxifene induced more relaxation in blood vessels isolated from male than female rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550571     DOI: 10.1124/jpet.104.077990

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

Review 1.  Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Authors:  Durr-e-Nayab Masood; Emir C Roach; Katie G Beauregard; Raouf A Khalil
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

2.  Bazedoxifene-induced vasodilation and inhibition of vasoconstriction is significantly greater than estradiol.

Authors:  Margaret A Zimmerman; Dillion D Hutson; Franck Mauvais-Jarvis; Sarah H Lindsey
Journal:  Menopause       Date:  2019-02       Impact factor: 2.953

Review 3.  Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.

Authors:  Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-01

4.  Role of inducible nitric oxide synthase in endothelium-independent relaxation to raloxifene in rat aorta.

Authors:  Chi Ming Wong; Chak Leung Au; Suk Ying Tsang; Chi Wai Lau; Xiaoqiang Yao; Zongwei Cai; Arthur Chi-Kong Chung
Journal:  Br J Pharmacol       Date:  2017-02-27       Impact factor: 8.739

5.  Role of lipoxygenase metabolites of arachidonic acid in enhanced pulmonary artery contractions of female rabbits.

Authors:  Sandra L Pfister
Journal:  Hypertension       Date:  2011-02-07       Impact factor: 10.190

6.  Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease.

Authors:  Graciliano R A do Nascimento; Yaskara V R Barros; Amanda K Wells; Raouf A Khalil
Journal:  Curr Hypertens Rev       Date:  2009-11

Review 7.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

8.  Raloxifene protects endothelial cell function against oxidative stress.

Authors:  C M Wong; L M Yung; F P Leung; S-Y Tsang; C L Au; Z-Y Chen; X Yao; C H K Cheng; C-W Lau; M Gollasch; Y Huang
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

9.  Therapeutic concentrations of raloxifene augment nitric oxide-dependent coronary artery dilatation in vitro.

Authors:  F P Leung; L M Yung; H S Leung; C L Au; X Yao; P M Vanhoutte; I Laher; Y Huang
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

10.  Alleviation of Inflammation and Oxidative Stress in Pressure Overload-Induced Cardiac Remodeling and Heart Failure via IL-6/STAT3 Inhibition by Raloxifene.

Authors:  Shengqi Huo; Wei Shi; Haiyan Ma; Dan Yan; Pengcheng Luo; Junyi Guo; Chenglong Li; Jiayuh Lin; Cuntai Zhang; Sheng Li; Jiagao Lv; Li Lin
Journal:  Oxid Med Cell Longev       Date:  2021-03-20       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.